Supplemental Annuity Collective Trust of NJ maintained its position in shares of CME Group Inc. (NASDAQ:CME) during the second quarter, according to its most recent disclosure with the SEC. The institutional investor owned 9,165 shares of the financial services provider’s stock at the end of the second quarter. Supplemental Annuity Collective Trust of NJ’s holdings in CME Group were worth $1,148,000 as of its most recent SEC filing.
Several other institutional investors also recently modified their holdings of CME. Huntington National Bank raised its position in shares of CME Group by 4.7% in the first quarter. Huntington National Bank now owns 851 shares of the financial services provider’s stock worth $100,000 after buying an additional 38 shares during the last quarter. Coconut Grove Bank raised its position in shares of CME Group by 95.7% in the first quarter. Coconut Grove Bank now owns 900 shares of the financial services provider’s stock worth $107,000 after buying an additional 440 shares during the last quarter. Whittier Trust Co. raised its position in shares of CME Group by 12.6% in the first quarter. Whittier Trust Co. now owns 1,030 shares of the financial services provider’s stock worth $122,000 after buying an additional 115 shares during the last quarter. Parallel Advisors LLC raised its position in shares of CME Group by 4.1% in the first quarter. Parallel Advisors LLC now owns 1,084 shares of the financial services provider’s stock worth $128,000 after buying an additional 43 shares during the last quarter. Finally, RidgeWorth Capital Management LLC raised its position in shares of CME Group by 55.5% in the first quarter. RidgeWorth Capital Management LLC now owns 1,138 shares of the financial services provider’s stock worth $135,000 after buying an additional 406 shares during the last quarter. 83.17% of the stock is currently owned by hedge funds and other institutional investors.
Shares of CME Group Inc. (NASDAQ CME) opened at 125.83 on Friday. The firm’s 50-day moving average is $123.71 and its 200 day moving average is $120.57. CME Group Inc. has a 12 month low of $98.95 and a 12 month high of $127.96. The stock has a market cap of $42.60 billion, a PE ratio of 25.68 and a beta of 0.73.
CME Group (NASDAQ:CME) last announced its quarterly earnings results on Tuesday, August 1st. The financial services provider reported $1.23 earnings per share for the quarter, topping the consensus estimate of $1.20 by $0.03. CME Group had a net margin of 46.05% and a return on equity of 7.61%. The company had revenue of $925 million for the quarter, compared to analysts’ expectations of $931.05 million. During the same quarter in the previous year, the business posted $1.14 earnings per share. CME Group’s quarterly revenue was up 2.1% on a year-over-year basis. On average, equities analysts predict that CME Group Inc. will post $4.82 EPS for the current year.
The firm also recently declared a quarterly dividend, which will be paid on Monday, September 25th. Investors of record on Friday, September 8th will be given a $0.66 dividend. This represents a $2.64 annualized dividend and a yield of 2.10%. The ex-dividend date is Thursday, September 7th. CME Group’s dividend payout ratio is presently 53.99%.
Several equities analysts recently commented on CME shares. BidaskClub lowered shares of CME Group from a “hold” rating to a “sell” rating in a report on Friday, July 28th. Royal Bank Of Canada increased their target price on shares of CME Group from $130.00 to $135.00 and gave the company an “outperform” rating in a report on Tuesday, June 20th. Jefferies Group LLC reaffirmed a “buy” rating and set a $134.00 target price (up previously from $128.00) on shares of CME Group in a report on Monday, July 17th. Zacks Investment Research lowered shares of CME Group from a “hold” rating to a “sell” rating in a report on Tuesday, July 11th. Finally, UBS AG reaffirmed a “buy” rating and set a $134.00 target price (down previously from $136.00) on shares of CME Group in a report on Monday, June 5th. One research analyst has rated the stock with a sell rating, three have issued a hold rating and five have given a buy rating to the company. CME Group has an average rating of “Hold” and a consensus target price of $131.63.
In other CME Group news, insider Derek Sammann sold 2,100 shares of the business’s stock in a transaction on Monday, June 5th. The shares were sold at an average price of $117.86, for a total transaction of $247,506.00. Following the transaction, the insider now owns 31,026 shares in the company, valued at $3,656,724.36. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at this hyperlink. Also, CFO John W. Pietrowicz sold 2,500 shares of the business’s stock in a transaction on Monday, July 10th. The shares were sold at an average price of $124.50, for a total transaction of $311,250.00. Following the transaction, the chief financial officer now owns 38,495 shares in the company, valued at approximately $4,792,627.50. The disclosure for this sale can be found here. Insiders sold 69,770 shares of company stock worth $8,569,114 in the last 90 days. 0.61% of the stock is currently owned by company insiders.
About CME Group
CME Group Inc, through its exchanges, provides products across all asset classes, including futures and options based on interest rates, equity indexes, foreign exchange, energy, agricultural products and metals. The Company’s segment primarily consists of the Chicago Mercantile Exchange Inc (CME), Board of Trade of the City of Chicago, Inc (CBOT), New York Mercantile Exchange, Inc (NYMEX) and Commodity Exchange, Inc (COMEX) exchanges.
Want to see what other hedge funds are holding CME? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for CME Group Inc. (NASDAQ:CME).
Receive News & Ratings for CME Group Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CME Group Inc. and related companies with MarketBeat.com's FREE daily email newsletter.
